Elabscience
SKU:E-AB-F1001H
PE/Cyanine7 Anti-Human CD3 Antibody[OKT3]
PE/Cyanine7 Anti-Human CD3 Antibody[OKT3]
Couldn't load pickup availability
PE/Cyanine7 Anti-Human CD3 Antibody[OKT3]
Introducing the PE/Cyanine7 Anti-Human CD3 Antibody [OKT3], a cutting-edge product designed to revolutionize immunological research and diagnostics. This antibody, conjugated with the highly efficient PE/Cyanine7 fluorochrome, offers exceptional specificity and sensitivity in detecting human CD3 expression.
The PE/Cyanine7 Anti-Human CD3 Antibody [OKT3] is meticulously engineered using advanced techniques, ensuring its superior performance and reliability. With its high affinity for the CD3 antigen, this antibody enables precise identification and quantification of CD3-positive cells, facilitating accurate analysis of T-cell populations.
This product's exceptional fluorescence properties, combined with its low background noise, guarantee optimal signal-to-noise ratios, enhancing the accuracy and reproducibility of experimental results. Its compatibility with various flow cytometry platforms further enhances its versatility and applicability in diverse research settings.
The PE/Cyanine7 Anti-Human CD3 Antibody [OKT3] is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reliability. Its long shelf life and stability make it an ideal choice for long-term storage and repeated use, minimizing experimental variability.
This antibody's exceptional performance, reliability, and compatibility make it an indispensable tool for immunologists, researchers, and clinicians alike. Whether investigating T-cell biology, studying immune responses, or diagnosing immunological disorders, the PE/Cyanine7 Anti-Human CD3 Antibody [OKT3] is the ultimate solution for precise and accurate CD3 detection.
Experience the future of immunological research and diagnostics with the PE/Cyanine7 Anti-Human CD3 Antibody [OKT3]. Unlock new insights and advance your scientific endeavors with this state-of-the-art antibody.
Share
